Science Explorer Back to mapMap

Most cited papers from Genomas (United States)

What are the most cited papers from Genomas (United States)?

The most cited paper from Genomas (United States) is "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy" (Kristine R. Crews et al., 2021), with 427 citations. Next come "Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA" (280) and "Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia" (261).

Showing 50 of 75 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy Kristine R. Crews et al. · Clinical Pharmacology & Therapeutics Open access 2 Jan 2021 427
2 Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA Jingyu Liu, Godfrey D. Pearlson, Andreas Windemuth et al. · Human Brain Mapping Open access 10 Dec 2007 280
3 Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia Shashwath A. Meda, Gualberto Ruaño, Andreas Windemuth et al. · Proceedings of the National Academy of Sciences Open access 28 Apr 2014 261
4 PharmVar GeneFocus: CYP2D6 Charity Nofziger, Amy Jane Turner, Katrin Sangkuhl et al. · Clinical Pharmacology & Therapeutics Open access 23 Sep 2019 254
5 A clinical study of the association of antipsychotics with hyperlipidemia José de León, Margaret T. Susce, Maria S. Johnson et al. · Schizophrenia Research 9 Mar 2007 77
6 Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities José de León, Maria Jesús Arranz, Gualberto Ruaño · Clinics in Laboratory Medicine Dec 2008 74
7 Physiogenomic association of statin‐related myalgia to serotonin receptors Gualberto Ruaño, Paul D. Thompson, Andreas Windemuth et al. · Muscle & Nerve 28 Jun 2007 73
8 New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals Richard Judson, Carlos W. Brain, Brad Dain et al. · Atherosclerosis 10 Sep 2004 65
9 Mechanisms of statin-induced myalgia assessed by physiogenomic associations Gualberto Ruaño, Andreas Windemuth, Alan H.B. Wu et al. · Atherosclerosis Open access 24 Jul 2011 64
10 Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients Gualberto Ruaño, John W. Goethe, Charles F. Caley et al. · Molecular Psychiatry 2 Jan 2007 62
11 Genetic Associations of Brain Structural Networks in Schizophrenia: A Preliminary Study Kanchana Jagannathan, Vince D. Calhoun, Joel E. Gelernter et al. · Biological Psychiatry Open access 6 Aug 2010 56
12 Length of Psychiatric Hospitalization is Correlated With CYP2D6 Functional Status in Inpatients with Major Depressive Disorder Gualberto Ruaño, Bonnie L. Szarek, David Villagra et al. · Biomarkers in Medicine Open access Jun 2013 47
13 Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels José de León, Juan Carlos Correa, Gualberto Ruaño et al. · Schizophrenia Research Dec 2007 45
14 Ethnogeographic Prevalence and Implications of the 677C>T and 1298A>C MTHFR Polymorphisms in Us Primary Care Populations James S. Graydon, Karla Claudio, Seth H. Baker et al. · Biomarkers in Medicine Open access Jun 2019 44
15 Physiogenomic Analysis Links Serum Creatine Kinase Activities During Statin Therapy to Vascular Smooth Muscle Homeostasis Gualberto Ruaño, Paul Daniel Thompson, Andreas Windemuth et al. · Pharmacogenomics 21 Nov 2005 44
16 Multivariate genetic determinants of EEG oscillations in schizophrenia and psychotic bipolar disorder from the BSNIP study Balaji Narayanan, Pauline Soh, Vince D. Calhoun et al. · Translational Psychiatry Open access 23 Jun 2015 43
17 Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training Gualberto Ruaño, Richard L. Seip, Andreas Windemuth et al. · Atherosclerosis Open access 12 Jul 2005 41
18 Quo vadis personalized medicine? Gualberto Ruaño · Personalized Medicine Dec 2004 39
19 A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics Jorge Duconge-Soler, Alga S Ramos, Karla Claudio‐Campos et al. · PLoS ONE Open access 8 Jan 2016 36
20 Retrospective validation of genomic biomarkers – what are the questions, challenges and strategies for developing useful relationships to clinical outcomes – workshop summary S-J Wang, Nadine Cohen, David A. Katz et al. · The Pharmacogenomics Journal 10 Jan 2006 32
21 Physiogenomic Analysis of the Puerto Rican Population Gualberto Ruaño, Jorge Duconge-Soler, Andreas Windemuth et al. · Pharmacogenomics Open access Apr 2009 31
22 Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction Gualberto Ruaño, Andreas Windemuth, Mohan Kocherla et al. · Nutrition & Metabolism Open access 15 May 2006 31
23 Novel Drug Metabolism Indices for Pharmacogenetic Functional Status Based on Combinatory Genotyping of CYP2C9 , CYP2C19 and CYP2D6 Genes David Villagra, John W. Goethe, Harold I. Schwartz et al. · Biomarkers in Medicine Open access Aug 2011 29
24 Pharmacogenomic Data Submissions to the FDA: Clinical Pharmacology Case Studies Gualberto Ruaño, Jerry M. Collins, Andrew J. Dorner et al. · Pharmacogenomics Jul 2004 29
25 Implementing genotype-guided Antithrombotic Therapy Richard L. Seip, Jorge Duconge-Soler, Gualberto Ruaño · Future Cardiology Open access May 2010 28
26 Development of a Pharmacogenetic-Guided Warfarin Dosing Algorithm for Puerto Rican Patients Alga S Ramos, Richard L. Seip, Giselle C Rivera-Miranda et al. · Pharmacogenomics Open access Dec 2012 28
27 Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone Gualberto Ruaño, James L Bernene, Andreas Windemuth et al. · Clinica Chimica Acta 27 Oct 2008 27
28 Results of the CYP-GUIDES randomized controlled trial: Total cohort and primary endpoints Gualberto Ruaño, Saskia Robinson, Theodore R. Holford et al. · Contemporary Clinical Trials 12 Dec 2019 25
29 CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies David Villagra, Jorge Duconge-Soler, Andreas Windemuth et al. · Clinica Chimica Acta Open access 20 May 2010 24
30 Physiogenomic Analysis of Localized fMRI Brain Activity in Schizophrenia Andreas Windemuth, Vince D. Calhoun, Godfrey D. Pearlson et al. · Annals of Biomedical Engineering Open access 10 Mar 2008 23
31 Physiogenomic Analysis of CYP450 Drug Metabolism Correlates Dyslipidemia With Pharmacogenetic Functional Status in Psychiatric Patients Gualberto Ruaño, David Villagra, Bonnie L. Szarek et al. · Biomarkers in Medicine Open access Aug 2011 22
32 Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms. Gualberto Ruaño, Jonathan A Kost · PubMed Nov 2018 21
33 Isolation of Microsporum gypseum in soil samples from different geographical regions of Brazil, evaluation of the extracellular proteolytic enzymes activities (keratinase and elastase) and molecular sequencing of selected strains Mauro Cintra Giudice, Adriana Araújo Reis-Menezes, Glauce Mary Gomes Rittner et al. · Brazilian Journal of Microbiology Open access Sep 2012 21
34 Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study Karla Claudio‐Campos, Aurora Labastida, Alga S Ramos et al. · Frontiers in Pharmacology Open access 7 Jun 2017 20
35 Prediction of Warfarin Dose Reductions in Puerto Rican Patients, Based on Combinatorial CYP2C9 and VKORCI Genotypes Isa Ivette Valentin, Joan Vazquez, Giselle C Rivera-Miranda et al. · Annals of Pharmacotherapy Open access 24 Jan 2012 19
36 Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat Richard L. Seip, Jeff S. Volek, Andreas Windemuth et al. · Nutrition & Metabolism Open access 6 Feb 2008 19
37 Acetyl-coenzyme A carboxylase α gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels Francisco J. Díaz, Alexander Meary, Maria Jesús Arranz et al. · Schizophrenia Research Open access 28 Oct 2009 18
38 VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study Paulo L. Lizano, Olivia Lutz, George M. Ling et al. · Translational Psychiatry Open access 11 Oct 2018 16
39 Pharmacogenetic Testing for Analgesic Adverse Effects Renee C.B. Manworren, Lauren Jeffries, Ashley Pantaleao et al. · Clinical Journal of Pain 24 Mar 2015 15
40 Practical interpretation of CYP2D6 haplotypes: Comparison and integration of automated and expert calling Gualberto Ruaño, Mohan Kocherla, James S. Graydon et al. · Clinica Chimica Acta 20 Feb 2016 14
41 High Carrier Prevalence of Deficient and Null Alleles of CYP2 Genes in a Major USA Hospital: Implications for Personalized Drug Safety Gualberto Ruaño, Greg Makowski, Andreas Windemuth et al. · Personalized Medicine May 2006 14
42 Increased Carrier Prevalence Of Deficient Cyp2C9 , Cyp2C19 and Cyp2D6 Alleles in Depressed Patients Referred to a Tertiary Psychiatric Hospital Gualberto Ruaño, David Villagra, Umme Salma Rahim et al. · Personalized Medicine Nov 2008 13
43 Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service Idaliz Rodríguez‐Escudero, Julio A. Cedeño, Ileana Rodríguez‐Nazario et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY Open access 2 May 2020 11
44 Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses Neeraj Tandon, Pranav Nanda, Jaya L. Padmanabhan et al. · Schizophrenia Research 24 Oct 2016 11
45 Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study Mohammadreza Mokhtari, Balaji Narayanan, Jordan P. Hamm et al. · Schizophrenia Bulletin Open access 12 Oct 2015 11
46 Guidance of pharmacotherapy in a complex psychiatric case by CYP450 DNA typing Joan Landino, Jane Buckley, John M. Roy et al. · Journal of the American Academy of Nurse Practitioners 25 Jul 2011 11
47 Physiogenomic Analysis of Statin-Treated Patients: Domain-Specific Counter Effects within the ACACB Gene on Low-Density Lipoprotein Cholesterol? Gualberto Ruaño, Paul Daniel Thompson, John P. Kane et al. · Pharmacogenomics Open access Jul 2010 10
48 High Carrier Prevalence of Combinatorial CYP2C9 and VKORC1 Genotypes Affecting Warfarin Dosing Gualberto Ruaño, Paul D Thompson, David Villagra et al. · Personalized Medicine May 2008 10
49 Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies. Gualberto Ruaño, Catherine Blair, Bruce Bower et al. · PubMed Apr 2007 8
50 A novel approach to analyzing fMRI and SNP data via parallel independent component analysis Jingyu Liu, Godfrey D. Pearlson, Vince D. Calhoun et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Conference paper 8 Mar 2007 7

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.